Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets
The company informed that these tablets, to be marketed under brand name Favizen, will be manufactured with in-house API
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.